Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
Tumor necrosis factor (TNF) family members participate in the body’s antitumor immunity response and influence tumor prognosis and treatment response. However, little is known about the roles of TNF family members in small cell lung cancer (SCLC). Therefore, we conducted the first comprehensive inve...
Enregistré dans:
Auteurs principaux: | Zhihui Zhang, Peng Wu, Chaoqi Zhang, Yuejun Luo, Guochao Zhang, Qingpeng Zeng, Lide Wang, Zhaoyang Yang, Nan Sun, Jie He |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/043e68500fe84285a2abee0da4e37ff8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
par: Zhihui Zhang, et autres
Publié: (2021) -
m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
par: Zhihui Zhang, et autres
Publié: (2021) -
Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
par: Yin Jin, et autres
Publié: (2021) -
Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
par: Minami S, et autres
Publié: (2016) -
Mastectomy skin flap necrosis: challenges and solutions
par: Robertson SA, et autres
Publié: (2017)